Page last updated: 2024-08-24

triazoles and Carcinoma

triazoles has been researched along with Carcinoma in 51 studies

Research

Studies (51)

TimeframeStudies, this research(%)All Research%
pre-19904 (7.84)18.7374
1990's2 (3.92)18.2507
2000's21 (41.18)29.6817
2010's23 (45.10)24.3611
2020's1 (1.96)2.80

Authors

AuthorsStudies
Abid, S; Ayed-Boussema, I; Azzebi, A; Hamdi, H; Rjiba-Touati, K1
Banerjee, S; Della Pepa, C; George, A; Gore, M; Kaye, S; McLachlan, J; Migali, C; Tunariu, N1
Busson, P; Guo, X; Ke, L; Khabir, A; Kieff, E; Ling, Y; Tsao, GS; Wang, C; Xiang, Y; Xiong, G; Zeng, M; Zeng, Y; Zhao, B; Zhou, H1
El-Baradie, KY; El-Sayed, YS; Fahmy, RM; Gaber, M1
Bei, JX; Chen, LZ; Feng, QS; Liang, Y; Min, P; Wang, GF; Wang, HB; Wu, MS; Wu, MY; Yang, D; Zeng, YX; Zhao, ZQ1
Ganjekar, S; Kilara, N; Mahendra, JV; Manjunatha, N; Srinivasa, R1
Osborne, CK; Rimawi, MF; Schiff, R1
Beedle, AM; Hanold, LE; Kannan, N; Kennedy, EJ; Oruganty, K; Ton, NT1
Cai, MC; Di, W; Gao, WQ; Gu, Z; Ji, ZL; Jing, Y; Ma, P; Peng, H; Yan, Y; Zhang, M; Zhang, S; Zhang, Z; Zhuang, G1
Baldan, F; Conzatti, K; Damante, G; Di Cristofano, A; Di Loreto, C; Durante, C; Filetti, S; Lavarone, E; Mio, C; Orlacchio, A; Puppin, C; Russo, D; Toffoletto, B1
Niraula, S; Ocana, A1
Billig, H; Bootz, F; Brägelmann, J; Brossart, P; Kirfel, J; Kristiansen, G; Perner, S; Queisser, A; Schröck, A; Thewes, B; Vogel, W; von Mässenhausen, A1
Bagnardi, V; Balduzzi, A; Bertolini, F; Cardillo, A; Colleoni, M; Goldhirsch, A; Mancuso, P; Montagna, E; Orlando, L; Scarano, E; Torrisi, R; Veronesi, P; Viale, G1
Barker, LC; Brand, IR; Crawford, SM1
de Melo, SJ; do Nascimento, SC; dos Anjos, JV; Neves Filho, RA; Sinou, D; Srivastava, RM1
Mazur, L; Mendyk, E; Pachuta-Stec, A; Pitucha, M; Rzaczyńska, Z; Rzymowska, J1
Liang, XW; Lin, SL; Qiao, J; Schatten, H; Sun, QY; Wang, ZB; Wang, ZY; Yan, LY1
Dieras, V; Florance, A; Gomez, HL; Johnston, S; Kennedy, MJ; Lichinitser, M; Maltzman, J; Manikhas, A; O'Rourke, L; Oliva, C; Pegram, M; Pippen, J; Pivot, X; Press, MF; Romieu, G; Sadeghi, S; Stein, S1
Hao, Q; Hu, YL; Liang, YJ; Wang, JD; Wang, QL; Wu, YZ1
Doyen, J; Ferrero, JM; Fontana, X; Italiano, A; Largillier, R; Thyss, A1
Apatira, A; Brandt, R; Chang, B; Chua, J; Ding, P; Duan, M; Franci, C; Goff, D; Heckrodt, TJ; Hitoshi, Y; Holland, SJ; Hu, Y; Li, W; Pan, A; Payan, DG; Pine, P; Singh, R; Torneros, A; Yu, J; Zhang, J1
Beriwal, S; Bhargava, R; Dabbs, DJ; O'Connor, SM1
Buchanan, SG; Dekoning, T; Eagleson, B; Essenburg, C; Kang, L; Kaufman, D; Staal, B; Su, Y; Vande Woude, GF; West, R; Zhang, YW1
Cochrane, RA; Davie, MW; Powell, DE1
Coşkun, U; Oktay, K; Sönmezer, M; Türkçüoğlu, I1
Anderson, H; Buffa, FM; Detre, S; Dexter, T; Dowsett, M; Dunbier, AK; Ghazoui, Z; Harris, AL; Salter, J; Smith, IE1
Bagalà, C; Barone, C; Basso, M; Cerchiaro, E; D'Argento, E; Inno, A; Marsico, VA; Vecchio, FM1
Bedard, PL; Bradbury, I; Desmedt, C; Dixon, JM; Evans, DB; Haibe-Kains, B; Ignatiadis, M; Loi, S; Michiels, S; Miller, WR; Piccart, MJ; Singhal, SK; Sotiriou, C1
Argonza-Aviles, E; Beck, JT; Bosserman, L; Brufsky, AM; Ericson, SG; Harker, WG; Hohneker, J; Jin, L; Perez, EA; Seidler, C; Vogel, C; Warsi, G1
Hozumi, Y; Ohashi, Y; Ohsumi, S; Shimozuma, K; Suemasu, K; Takehara, M; Takei, H1
Amonkar, MM; Diaz, JR; Forbes, CA; Kleijnen, J; Lykopoulos, K; Rea, DW; Riemsma, R1
Ali, SM; Carney, W; Chaudri-Ross, HA; Demers, L; Evans, D; Hackl, W; Hamer, P; Harvey, HA; Lang, R; Leitzel, K; Lipton, A1
Boulay, A; Chen, S; Evans, DB; Lane, HA; O'Reilly, T; Rudloff, J; Ye, J; Zumstein-Mecker, S1
Bria, E; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Felici, A; Ferretti, G; Giannarelli, D; Milella, M; Mottolese, M; Nisticò, C; Papaldo, P; Ruggeri, EM; Terzoli, E1
Rennie, I; Rundle, P1
Ali, SM; Carney, W; Chaudri-Ross, HA; Demers, L; Evans, DB; Hackl, W; Hamer, P; Leitzel, K; Lipton, A; Souder, C1
Abrial, C; Chollet, P; Curé, H; Durando, X; Leheurteur, M; Mouret-Reynier, MA; Tacca, O1
DiLeonardo, M; Gibbons, G; Resnik, KS1
Costantino, J; Cronin, W; Geyer, C; Harkins, B; Jeong, JH; Lembersky, B; Mamounas, EP; Paik, S; Wickerham, DL; Wolmark, N1
Nortier, JW; Seynaeve, C; van de Velde, CJ; van Nes, JG1
Chishima, T; Ichikawa, Y; Inui, K; Ishikawa, T; Matsumoto, C; Momiyama, N; Shimada, H; Togo, S1
Bell, R; Lewis, J1
Detre, S; Dowsett, M; Grimshaw, R; Lee, K; Macaulay, VM; Rowlands, M1
Buzdar, AU; Jones, SE; Plourde, P; Vogel, CL; Webster, A; Wolter, J1
Bell, J; Brunetto, VL; Lee, RB; Rose, PG; VanLe, L; Walker, JL1
Christov, K; Graves, J; Hu, L; Kelloff, G; Lubet, R; Mehta, RR; Shilkaitis, A; Steele, V; You, M1
Bijnens, L; Michiels, B; Molenberghs, G; Thijs, H; Vangeneugden, T1
Khare, GP; Robins, RK; Sidwell, RW; Witkowski, JT1
Tjälve, H1
Tudhope, GR1
Pliss, MB; Rubenchik, BL; Shipko, GP1

Reviews

6 review(s) available for triazoles and Carcinoma

ArticleYear
Targeting HER2 for the treatment of breast cancer.
    Annual review of medicine, 2015, Volume: 66

    Topics: Anastrozole; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Female; Humans; Lapatinib; Nitriles; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Trastuzumab; Triazoles

2015
Mechanism of drug resistance in relation to site of metastasis: Meta-analyses of randomized controlled trials in advanced breast cancer according to anticancer strategy.
    Cancer treatment reviews, 2016, Volume: 50

    Topics: Anastrozole; Androstadienes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Disease-Free Survival; Drug Resistance, Neoplasm; Estradiol; Everolimus; Female; Fulvestrant; Humans; Letrozole; Nitriles; Piperazines; Pyridines; Randomized Controlled Trials as Topic; Trastuzumab; Triazoles

2016
Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+ advanced or metastatic breast cancer(MBC).
    Current medical research and opinion, 2012, Volume: 28, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Disease Progression; Female; Humans; Lapatinib; Letrozole; Neoadjuvant Therapy; Neoplasm Metastasis; Nitriles; Quinazolines; Receptor, ErbB-2; Receptors, Cytoplasmic and Nuclear; Triazoles

2012
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials.
    Cancer, 2005, Oct-01, Volume: 104, Issue:7

    Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Probability; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Triazoles

2005
[Optimal adjuvant hormone therapy in postmenopausal women with hormone-sensitive mammary carcinoma: tamoxifen and the aromatase inhibitors anastrozole, exemestane and letrozole].
    Nederlands tijdschrift voor geneeskunde, 2006, Dec-30, Volume: 150, Issue:52

    Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Letrozole; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles

2006
The control and biological importance of intratumoural aromatase in breast cancer.
    The Journal of steroid biochemistry and molecular biology, 1996, Volume: 56, Issue:1-6 Spec N

    Topics: Adenocarcinoma; Androgens; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Male; Mice; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Nitriles; Triazoles; Tumor Cells, Cultured

1996

Trials

7 trial(s) available for triazoles and Carcinoma

ArticleYear
Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Nov-20, Volume: 27, Issue:33

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Disease-Free Survival; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Lapatinib; Letrozole; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nitriles; Postmenopause; Prognosis; Proportional Hazards Models; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Risk Assessment; Survival Analysis; Treatment Outcome; Triazoles

2009
Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole.
    Cancer, 2012, Mar-01, Volume: 118, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents; Bone and Bones; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Letrozole; Middle Aged; Nitriles; Organ Size; Osteoporosis, Postmenopausal; Postmenopause; Triazoles; Zoledronic Acid

2012
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-
    Breast cancer research and treatment, 2012, Volume: 133, Issue:1

    Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Depression; Female; Humans; Maintenance Chemotherapy; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Quality of Life; Stress, Psychological; Surveys and Questionnaires; Tamoxifen; Treatment Outcome; Triazoles

2012
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer.
    Cancer, 2006, Nov-15, Volume: 107, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Double-Blind Method; ErbB Receptors; Female; Humans; Letrozole; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Nitriles; Prognosis; Receptor, ErbB-2; Survival Analysis; Tamoxifen; Triazoles

2006
NSABP B-42: a clinical trial to determine the efficacy of five years of letrozole compared with placebo in patients completing five years of hormonal therapy consisting of an aromatase inhibitor (AI) or tamoxifen followed by an AI in prolonging disease-fr
    Clinical breast cancer, 2006, Volume: 7, Issue:5

    Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Letrozole; Neoplasm Staging; Nitriles; Patient Selection; Postmenopause; Tamoxifen; Triazoles

2006
A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.
    Cancer, 1997, Feb-15, Volume: 79, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Pregnanes; Triazoles

1997
A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.
    Gynecologic oncology, 2000, Volume: 78, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Carcinoma; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Triazoles

2000

Other Studies

38 other study(ies) available for triazoles and Carcinoma

ArticleYear
Bromuconazole fungicide induces cell cycle arrest and apoptotic cell death in cultured human colon carcinoma cells (HCT116) via oxidative stress process.
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2022, Volume: 27, Issue:7

    Topics: Acetylcysteine; Apoptosis; Biomarkers; Carcinoma; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Colon; DNA; Fluorescein-5-isothiocyanate; Fungicides, Industrial; Humans; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase; Triazoles

2022
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole.
    BMC cancer, 2017, Jun-30, Volume: 17, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoma; Female; Humans; Letrozole; Middle Aged; Neoplasm Grading; Neoplasm Staging; Nitriles; Ovarian Neoplasms; Receptors, Estrogen; Recurrence; Retreatment; Retrospective Studies; Tamoxifen; Treatment Outcome; Triazoles; Young Adult

2017
Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 09-05, Volume: 114, Issue:36

    Topics: Adolescent; Adult; Aged; Animals; Azepines; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; Enhancer Elements, Genetic; Epigenesis, Genetic; Epstein-Barr Virus Infections; ETS Translocation Variant 6 Protein; Female; Genome, Viral; Heterografts; High-Throughput Nucleotide Sequencing; Histone Code; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nuclear Proteins; Prognosis; Proto-Oncogene Proteins c-ets; Repressor Proteins; Transcription Factors; Triazoles; Young Adult

2017
Complex formation, thermal behavior and stability competition between Cu(II) ion and Cu(0) nanoparticles with some new azo dyes. Antioxidant and in vitro cytotoxic activity.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2013, Apr-15, Volume: 107

    Topics: Animals; Antineoplastic Agents; Antioxidants; Azo Compounds; Benzothiazoles; Carcinoma; Coloring Agents; Coordination Complexes; Copper; Female; Mice; Nanoparticles; Spectrum Analysis; Sulfonic Acids; Thiadiazoles; Triazoles

2013
Smac mimetics in combination with TRAIL selectively target cancer stem cells in nasopharyngeal carcinoma.
    Molecular cancer therapeutics, 2013, Volume: 12, Issue:9

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Azocines; Baculoviral IAP Repeat-Containing 3 Protein; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Mice, Nude; Mitochondrial Proteins; Molecular Mimicry; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplastic Stem Cells; TNF-Related Apoptosis-Inducing Ligand; Triazoles; Ubiquitin-Protein Ligases; X-Linked Inhibitor of Apoptosis Protein; Xenograft Model Antitumor Assays

2013
Tardive dyskinesia associated with anastrozole.
    The Journal of neuropsychiatry and clinical neurosciences, 2013,Summer, Volume: 25, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Female; Humans; Middle Aged; Movement Disorders; Nitriles; Triazoles

2013
Inhibiting EGFR dimerization using triazolyl-bridged dimerization arm mimics.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: Allosteric Regulation; Carcinoma; Dimerization; Ectodysplasins; ErbB Receptors; Humans; Models, Molecular; Molecular Dynamics Simulation; Protein Engineering; Triazoles

2015
BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1.
    Theranostics, 2016, Volume: 6, Issue:2

    Topics: Animals; Antineoplastic Agents; Azepines; Carcinoma; Cell Line, Tumor; Down-Regulation; Female; Forkhead Box Protein M1; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Proteins; Ovarian Neoplasms; Pteridines; Transcription Factors; Triazoles

2016
MCM5 as a target of BET inhibitors in thyroid cancer cells.
    Endocrine-related cancer, 2016, Volume: 23, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Azepines; Benzodiazepines; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Mice, Knockout; Neoplasm Proteins; Nuclear Proteins; Thyroid Gland; Thyroid Neoplasms; Triazoles

2016
Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression.
    International journal of molecular sciences, 2016, Dec-22, Volume: 18, Issue:1

    Topics: Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Head and Neck Neoplasms; Humans; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Triazoles

2016
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.
    Anti-cancer drugs, 2009, Volume: 20, Issue:3

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carcinoma; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hematologic Diseases; Humans; Hypertension; Infusions, Intravenous; Letrozole; Mastectomy; Middle Aged; Nitriles; Paclitaxel; Prognosis; Proteinuria; Radiotherapy, Adjuvant; Triazoles

2009
Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma.
    Current medical research and opinion, 2009, Volume: 25, Issue:5

    Topics: Aged; Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Carcinoma; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Letrozole; Middle Aged; Neoplasm Metastasis; Nitriles; Organ Size; Retrospective Studies; Time Factors; Triazoles

2009
Synthesis and cytotoxic profile of glycosyl-triazole linked to 1,2,4-oxadiazole moiety at C-5 through a straight-chain carbon and oxygen atoms.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:9

    Topics: Antineoplastic Agents; Carbon; Carcinoma; Cell Line, Tumor; Cell Proliferation; Glycosylation; Humans; Laryngeal Neoplasms; Lung Neoplasms; Oxadiazoles; Oxygen; Triazoles

2009
Synthesis, structure elucidation and antitumour activity of N-substituted amides of 3-(3-ethylthio-1,2,4-triazol-5-yl)propenoic acid.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:9

    Topics: Amides; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Line; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Female; Fibroblasts; Humans; Lung Neoplasms; Skin; Triazoles

2009
A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells.
    Reproductive biology and endocrinology : RB&E, 2009, Sep-24, Volume: 7

    Topics: Aromatase Inhibitors; Carcinoma; Cell Membrane; Endometrial Neoplasms; Enzyme Activation; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Letrozole; Nitriles; Phosphorylation; Protein Isoforms; Proto-Oncogene Proteins c-akt; Signal Transduction; Testosterone; Triazoles; Tumor Cells, Cultured

2009
Aromatase inhibitor letrozole in synergy with curcumin in the inhibition of xenografted endometrial carcinoma growth.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Carcinoma; Cell Line, Tumor; Cell Proliferation; Curcumin; Down-Regulation; Drug Synergism; Endometrial Neoplasms; Female; Humans; Letrozole; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Triazoles; Xenograft Model Antitumor Assays

2009
Aromatase inhibition in male breast cancer patients: biological and clinical implications.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma; Estradiol; Humans; Letrozole; Male; Middle Aged; Neoplasm Metastasis; Nitriles; Retrospective Studies; Survival Analysis; Testosterone; Treatment Outcome; Triazoles

2010
R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.
    Cancer research, 2010, Feb-15, Volume: 70, Issue:4

    Topics: Animals; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Breast Neoplasms; Carcinoma; Female; HeLa Cells; Humans; K562 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Oncogene Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Survival Analysis; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2010
Concordance between semiquantitative immunohistochemical assay and oncotype DX RT-PCR assay for estrogen and progesterone receptors.
    Applied immunohistochemistry & molecular morphology : AIMM, 2010, Volume: 18, Issue:3

    Topics: Anastrozole; Anesthetics, Combined; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Early Detection of Cancer; Female; Gonadal Steroid Hormones; Humans; Immunohistochemistry; Neoplasm Recurrence, Local; Nitriles; Practice Guidelines as Topic; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Tamoxifen; Triazoles

2010
MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growth.
    Cancer research, 2010, Sep-01, Volume: 70, Issue:17

    Topics: Animals; Carcinoma; Cell Cycle; Cell Growth Processes; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Female; Hepatocyte Growth Factor; Humans; Mice; Mice, Inbred C3H; Mice, SCID; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyridazines; Quinazolines; Receptors, Growth Factor; Triazoles; Xenograft Model Antitumor Assays

2010
Does anastrozole affect bone resorption similarly in early and late postmenopausal women?
    Calcified tissue international, 2011, Volume: 88, Issue:3

    Topics: Age Factors; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Bone Density; Bone Resorption; Breast Neoplasms; Carcinoma; Case-Control Studies; Collagen Type I; Cross-Sectional Studies; Female; Humans; Middle Aged; Nitriles; Osteoporosis, Postmenopausal; Peptides; Postmenopause; Risk Factors; Triazoles

2011
Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles.
    Fertility and sterility, 2011, Volume: 95, Issue:6

    Topics: Adult; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Cryopreservation; Drug Administration Schedule; Emergency Medical Services; Female; Fertility; Humans; Infertility, Female; Letrozole; Menstrual Cycle; Nitriles; Oocyte Retrieval; Oocytes; Ovulation Induction; Preservation, Biological; Time Factors; Triazoles

2011
Close and stable relationship between proliferation and a hypoxia metagene in aromatase inhibitor-treated ER-positive breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, May-01, Volume: 17, Issue:9

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Nitriles; Predictive Value of Tests; Receptors, Estrogen; Sensitivity and Specificity; Triazoles

2011
Anastrozole-related acute hepatitis with autoimmune features: a case report.
    BMC gastroenterology, 2011, Mar-31, Volume: 11

    Topics: Acute Disease; Aged; Anastrozole; Antibodies, Antinuclear; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Female; Hepatitis, Autoimmune; Humans; Nitriles; Treatment Outcome; Triazoles

2011
Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.
    Endocrine-related cancer, 2011, Volume: 18, Issue:6

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Pharmacological; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Cell Proliferation; Cell Survival; Early Detection of Cancer; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Letrozole; Microarray Analysis; Middle Aged; Neoplasm, Residual; Nitriles; Prognosis; Receptors, Estrogen; Time Factors; Triazoles

2011
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy.
    Cancer, 2005, Jul-15, Volume: 104, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Disease Progression; Estrogen Antagonists; Female; Humans; Letrozole; Nitriles; Prognosis; Receptor, ErbB-2; Survival Analysis; Tamoxifen; Triazoles

2005
Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jul-15, Volume: 11, Issue:14

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Cell Proliferation; Cell Survival; Drug Interactions; Estrogens; Everolimus; Female; Humans; Immunosuppressive Agents; Letrozole; Nitriles; Protein Kinases; Receptors, Estrogen; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Triazoles; Tumor Cells, Cultured

2005
Photodynamic therapy for solitary retinal metastasis from breast carcinoma.
    Eye (London, England), 2006, Volume: 20, Issue:12

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Middle Aged; Nitriles; Photochemotherapy; Retinal Neoplasms; Triazoles

2006
Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer.
    Clinical breast cancer, 2006, Volume: 7, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Everolimus; Female; Humans; Letrozole; Nitriles; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Kinases; Sirolimus; TOR Serine-Threonine Kinases; Treatment Outcome; Triazoles

2006
Clinically occult cutaneous metastases.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6

    Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Capecitabine; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Lobular; Carcinoma, Signet Ring Cell; Deoxycytidine; Estradiol; Facial Neoplasms; Female; Fluorouracil; Fulvestrant; Humans; Incidental Findings; Letrozole; Mastectomy, Radical; Megestrol Acetate; Melanoma; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Nitriles; Selective Estrogen Receptor Modulators; Skin Neoplasms; Tamoxifen; Triazoles; Wound Healing

2006
[A case of advanced breast cancer with multiple liver metastases resistant to chemotherapy responding to high-dose toremifene].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Middle Aged; Nitriles; Quality of Life; Remission Induction; Toremifene; Triazoles

2007
Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer.
    Current medical research and opinion, 2007, Volume: 23, Issue:5

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colles' Fracture; Female; Fractures, Bone; Humans; Middle Aged; Nitriles; Postmenopause; Risk Assessment; Tamoxifen; Triazoles; Wrist Injuries

2007
Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 2000, Volume: 11, Issue:8

    Topics: Animals; Apoptosis; Aromatase Inhibitors; bcl-2-Associated X Protein; Carcinoma; Epithelial Cells; Female; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Animal; Precancerous Conditions; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; RNA, Messenger; Triazoles

2000
Selection models and pattern-mixture models to analyse longitudinal quality of life data subject to drop-out.
    Statistics in medicine, 2002, Apr-30, Volume: 21, Issue:8

    Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Female; Humans; Longitudinal Studies; Models, Statistical; Neoplasms, Hormone-Dependent; Patient Dropouts; Quality of Life; Triazoles

2002
Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides.
    Journal of medicinal chemistry, 1973, Volume: 16, Issue:8

    Topics: Adenoviridae; Amides; Animals; Antiviral Agents; Carcinoma; Cell Line; Cells, Cultured; Cytopathogenic Effect, Viral; Glycosides; Humans; Influenza, Human; Mice; Nasopharyngeal Neoplasms; Respirovirus; Rhinovirus; Simplexvirus; Triazoles

1973
X-accumulation of labelled aminotriazole in some transplanted tumours in mice.
    British journal of cancer, 1974, Volume: 30, Issue:2

    Topics: Animals; Autoradiography; Carbon Radioisotopes; Carcinoma; Fibrosarcoma; Intestines; Kidney; Liver; Lymphoma; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Spleen; Time Factors; Transplantation, Homologous; Triazoles

1974
The inhibition of catalase by plasma and by human tissue extracts.
    Clinica chimica acta; international journal of clinical chemistry, 1969, Volume: 25, Issue:3

    Topics: Ascorbic Acid; Blood; Carcinoma; Catalase; Conductometry; Dialysis; Edetic Acid; Erythrocytes; Ethylmaleimide; Hemolysis; Hot Temperature; Humans; Kidney; Liver; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Stomach Neoplasms; Tissue Extracts; Triazoles

1969
[Water-soluble and lipid-bound catalase in the liver and malignant tumors of rats].
    Ukrains'kyi biokhimichnyi zhurnal, 1966, Volume: 38, Issue:3

    Topics: Animals; Carcinoma; Catalase; Chemical Phenomena; Chemistry, Physical; Depression, Chemical; Lipid Metabolism; Liver; Neoplasms, Experimental; Rats; Sarcoma, Experimental; Solubility; Triazoles

1966